KERNX Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8/10
Best for: a rate that does not climb with the dose: $209 a month for semaglutide at every rung
KERNX Health scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $139 a month, paid up front; its compounded semaglutide, at $209, is 5% above the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
In the price
Coaching
In the price
Prices checked October 2026
KERNX Health sells compounded semaglutide and tirzepatide on flat monthly plans out of Washington, DC: $209 for semaglutide injections, $279 for semaglutide tablets and $299 for tirzepatide, the same at every dose, with the provider visits, health coaching and month-two lab work inside the price. A 12-month plan paid up front cuts semaglutide to $139 per four weeks. It does not name the pharmacy that fills the vial.
Is KERNX Health legit?
Yes. KERNX Health is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 8.0/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a KERNX Health promo or coupon code?
We know of no promo or coupon code for KERNX Health. Its listed price is $139 a month. Coupon sites advertising "KERNX Health discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how KERNX Health compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to KERNX Health
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Editorial score · methodology
KERNX Health at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $139/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping · Labs · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How KERNX Health scores
Six columns, each one computed from something KERNX Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.6/10$209/month is 5% above the $199 median for compounded semaglutide across the sellers we compare. A cheaper plan paid several months up front is also listed. A cheaper microdose price is also listed; Value is scored on the standard dose.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
10.0/10The price covers the medication, clinician visits, shipping, lab work and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on KERNX Health
Last checked October 2026- Checked the listed price across 8 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for KERNX Health
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with KERNX Health involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1KERNX Health shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask KERNX Health which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits, shipping, lab work and coaching.
- Lowest ongoing monthly price: semaglutide $139, tirzepatide $199. That leaves out membership fees, first-month rates and insurance copays.
- KERNX Health serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting KERNX Health
- KERNX Health offers email support
Cancelling KERNX Health
Taken from the terms KERNX Health publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None required. Month-to-month, or optional 3-, 6- or 12-month prepaid plans that renew for the same term.
- Refund policy
- Refund requests are reviewed on a case-by-case basis.
- Early-termination fee
- None
Medications KERNX Health lists
KERNX Health lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Flat $209/month at every dose KERNX publishes: 0.22, 0.44, 0.89, 1.5, 2.22 and 2.5 mg weekly. Covers medication, shipping, the provider consultation, monthly check-ins, health coaching and care team support. No membership fee and no separate consultation fee. Prepaid terms: 3 months (12 weeks) $597, 6 months (24 weeks) $1,074, 12 months below.
As low as $139 per 4-week supply. Renews for the same term unless canceled.
Compounded oral semaglutide, $279 a month. Prepaid: 3 months $777, 6 months $1,434.
As low as $209 per 4-week supply. Renews for the same term unless canceled.
Flat $299/month at every dose KERNX publishes: 2.2, 4.4, 6.6, 8.8, 11, 13.2 and 15 mg weekly. Covers medication, shipping, the provider consultation, monthly check-ins, health coaching and care team support. No membership fee and no separate consultation fee. Prepaid terms: 3 months (12 weeks) $717, 6 months (24 weeks) $1,374, 12 months below.
As low as $209 per 4-week supply. Renews for the same term unless canceled.
Lower-dose plan. Prepaid: 3 months $507, 6 months $954, 12 months $1,937 ($149 per 4 weeks).
Lower-dose plan. Prepaid: 3 months $507, 6 months $954, 12 months $1,937 ($149 per 4 weeks).
Check the price yourself before you pay
Every figure here comes from KERNX Health's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $299 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits, shipping, lab work and coaching
- Serves all 50 states
- We found no FDA warning letters issued to KERNX Health
Against it
- Semaglutide costs $209 a month, 5% above the $199 median for compounded semaglutide across the sellers we compare
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What KERNX Health charges
The standing price at KERNX Health is $139/month, unchanged as the dose goes up. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide (monthly): $209/month
- Compounded semaglutide (12-month plan): $139/month
- Compounded semaglutide (tablet): $279/month
- Compounded semaglutide (tablet, 12-month plan): $209/month
- Compounded tirzepatide (monthly): $299/month
- Compounded tirzepatide (12-month plan): $209/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so KERNX Health's $209 lands mid-market. Price is unlikely to be the deciding factor. Some of KERNX Health's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one.
Live Vital dispenses semaglutide and tirzepatide from $130/month, which makes it the fair comparison to run before you commit here.
What KERNX Health dispenses
KERNX Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder. KERNX Health also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at KERNX Health at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
KERNX Health tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. It also offers coaching as part of the plan. We found no FDA warning letters issued to KERNX Health. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If KERNX Health will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether KERNX Health bills your plan before you start.
It fits if
- you want the price to stop moving as your dose climbs
- injections are the thing keeping you from starting
- you want coaching bundled in rather than billed on top
- you need access wherever you live
Our read
KERNX Health lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. Ivim Health is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
KERNX Health scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $139 a month, paid up front; its compounded semaglutide, at $209, is 5% above the $199 median among the sellers we compare.
Before you pay KERNX Health
Starting at $139 a month. Check today's price, then start the intake.
Where KERNX Health is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
If none of these fits, our guide to alternatives to KERNX Health sets more sellers in the same category beside KERNX Health on price, states and what the price includes.
Frequently Asked Questions
How to check KERNX Health yourself
- How to Verify an Online GLP-1 Pharmacy: Six Public Checks
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
Every seller that ships to your state, side by side: California, Connecticut, Delaware, Hawaii, Indiana, Massachusetts, Utah, Virginia and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this KERNX Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See KERNX Health's current pricing
Plans start at $139 a month. Whether you qualify is a clinician's decision, made after your intake.